Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib vs Trastuzumab in HER2+ Breast Cancer with Specific Mutations
NCT03273595Phase 2Unknown
- Sponsor
- Xijing Hospital
- Start
- Jul 2016
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by Xijing Hospital. Status: unknown.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03273595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03273595.